Alliance Pharma and Ampersand acquire UK-based DDS

848
1
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, May 17 agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC

You need to subscribe for access to restricted content.

Sign up
Login:
Password:
Forgot your password?